PTPRC and neoplasm: As shown in the figure 5I,J, CCL2 significantly decreased the proportion of CD45+ CD11b+ F4/80+ CD206- (M1-like) TAMs and increased the CD45+ CD11b+ F4/80+ CD206+ (M2-like) TAMs in mouse tumor tissues.